Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin

Refinement of Macromolecular Structures by the Maximum-Likelihood Method

Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,671 · see citing works

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011 · see citing works

Improved methods for building protein models in electron density maps and the location of errors in these models

Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,650 · see citing works

Angiogenesis in cancer, vascular, rheumatoid and other disease

Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · see citing works

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.2.127 · Cited by 5,705 · see citing works

AMoRe: an automated package for molecular replacement

Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941 · see citing works

Crystallographic R Factor Refinement by Molecular Dynamics

Brünger, A. T., Kuriyan, J., & Karplus, M. (1987) · Science · doi:10.1126/science.235.4787.458 · Cited by 1,965 · see citing works

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

Ingber, D. E., Fujita, T., KISHIMOTO, S., Sudo, K., KANAMARU, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,292 · see citing works

Serine Proteases: Structure and Mechanism of Catalysis

Kraut, J. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.001555 · Cited by 1,253 · see citing works

ALSCRIPT: a tool to format multiple sequence alignments

Barton, G. J. (1993) · Protein Engineering Design and Selection · doi:10.1093/protein/6.1.37 · Cited by 1,144 · see citing works

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

Sin, N., Meng, L., Wang, M. Q. W., Wen, J., Bornmann, W. G., & Crews, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6099 · Cited by 634 · see citing works

Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin

Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y., Wu, Z., BIEMANN, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421 · see citing works

Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzyme

Roderick, S. L., & Matthews, B. W. (1993) · Biochemistry · doi:10.1021/bi00066a009 · Cited by 335 · see citing works

Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases.

Li, X., & Chang, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12357 · Cited by 294 · see citing works

Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.

Arfin, S. M., Kendall, R. L., Hall, L., Weaver, L. H., Stewart, A., Matthews, B. W., & Bradshaw, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7714 · Cited by 257 · see citing works

Fumagillin (H-3), a New Antibiotic with Amebicidal Properties

McCowen, M. C., Callender, M. E., & Lawlis, J. F. (1951) · Science · doi:10.1126/science.113.2930.202 · Cited by 172 · see citing works

AN ANTIPHAGE AGENT ISOLATED FROM ASPERGILLUS SP

Hanson, F. R., & Eble, T. E. (1949) · Journal of Bacteriology · doi:10.1128/jb.58.4.527-529.1949 · Cited by 129 · see citing works

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.

Dezube, B. J., Roenn, J. H. V., Holden‐Wiltse, J., Cheung, T., Remick, S. C., Cooley, T. P., Moore, J., Sommadossi, J., Shriver, S., Suckow, C., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1444 · Cited by 129 · see citing works

Microvessel quantification and its possible relation with liver metastasis in colorectal cancer

Tomisaki, S., Ohno, S., Ichiyoshi, Y., Kuwano, H., Maehara, Y., & Sugimachi, K. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8 · Cited by 118 · see citing works

Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins.

Kendall, R. L., & Bradshaw, R. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36737-7 · Cited by 97 · see citing works

Clinical trials of antiangiogenic agents

Twardowski, P. W., & Gradishar, W. J. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00015 · Cited by 62 · see citing works

Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma

Xia, J., Yang, B., Tang, Z., Sun, F.-X., Xue, Q., & Gao, D. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01240121 · Cited by 41 · see citing works

Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo

Singh, Y. P., Shikata, N., Kiyozuka, Y., Nambu, H., Morimoto, J., Kurebayashi, J., Hioki, K., & Tsubura, A. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005826129756 · Cited by 34 · see citing works

Inhibitory Effects of the Antiangiogenic Agent TNP-470 on Establishment and Growth of Hematogenous Metastasis of Human Pancreatic Carcinoma in SCID Beige Mice In Vivo

Kawarada, Y., Ishikura, H., Kishimoto, T., Saito, K., Takahashi, T., Kato, H., & Yoshiki, T. (1997) · Pancreas · doi:10.1097/00006676-199710000-00006 · Cited by 29 · see citing works

High-Resolution Crystals of Methionine Aminopeptidase fromPyrococcus furiosusObtained by Water-Mediated Transformation

Tahirov, T. H., Oki, H., Tomitake Tsukihara, A., Ogasahara, K., Yutani, K., Libeu, C. P., Izu, Y., Tsunasawa, S., & Kato, I. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3940 · Cited by 21 · see citing works

Angiostatic treatment of neuroblastoma

Wassberg, E., & Christofferson, R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00337-7 · Cited by 17 · see citing works

Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470

Ohta, Y., Watanabe, Y., Tabata, T., Oda, M., Hayashi, Y., Endo, Y., Tanaka, M., & Sasaki, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.89 · Cited by 17 · see citing works

Untitled work

Kanazawa (1996) · doi:10.1002/(sici)1097-0142(19960415)77:8+

Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation

Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609 · see citing works

Lessons from natural molecules

Clardy, J., & Walsh, C. T. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,178 · see citing works

Natural products to drugs: natural product-derived compounds in clinical trials

Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075 · see citing works

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology

Gehringer, M., & Laufer, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 754 · see citing works

Zinc coordination sphere in biochemical zinc sites

Auld, D. S. (2001) · BioMetals · doi:10.1023/a:1012976615056 · Cited by 734 · see citing works

The many faces of the helix-turn-helix domain: Transcription regulation and beyond

Aravind, L., Anantharaman, V., BALAJI, S., Babu, M. M., & IYER, L. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.008 · Cited by 702 · see citing works

Natural product and natural product derived drugs in clinical trials

Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Natural Product Reports · doi:10.1039/c4np00064a · Cited by 605 · see citing works

Natural products to drugs: natural product derived compounds in clinical trials

Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 493 · see citing works

Cinnamic Acid Derivatives as Anticancer Agents-A Review

De, P., Baltas, M., & Bedos‐Belval, F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795471347 · Cited by 448 · see citing works

Biosynthesis of fungal meroterpenoids

Matsuda, Y., & Abe, I. (2015) · Natural Product Reports · doi:10.1039/c5np00090d · Cited by 433 · see citing works

Oxidative Cyclization in Natural Product Biosynthesis

Tang, M., Zou, Y., Watanabe, K., Walsh, C. T., & Tang, Y. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00478 · Cited by 426 · see citing works

Structure, function and evolution of multidomain proteins

Vogel, C., Bashton, M., Kerrison, N. D., Chothia, C., & Teichmann, S. A. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.03.011 · Cited by 408 · see citing works

Endothelial α _ν β ₃ Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis

Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379 · see citing works

Metalloaminopeptidases: Common Functional Themes in Disparate Structural Surroundings

Lowther, W. T., & Matthews, B. W. (2002) · Chemical Reviews · doi:10.1021/cr0101757 · Cited by 347 · see citing works

Protein N-terminal methionine excision

Giglione, C., Boularot, A., & Meinnel, T. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3466-8 · Cited by 335 · see citing works

Structure and function of the methionine aminopeptidases

Lowther, W. T., & Matthews, B. W. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00271-x · Cited by 320 · see citing works

Chemical Genetics

Walsh, D. P., & Chang, Y. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296 · see citing works

Electrophilic natural products and their biological targets

Gersch, M., Kreuzer, J., & Sieber, S. A. (2012) · Natural Product Reports · doi:10.1039/c2np20012k · Cited by 282 · see citing works

Targeting Metalloenzymes for Therapeutic Intervention

Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 277 · see citing works

Coupling between Catalytic Site and Collective Dynamics: A Requirement for Mechanochemical Activity of Enzymes

Yang, L.-W., & Bahar, I. (2005) · Structure · doi:10.1016/j.str.2005.03.015 · Cited by 273 · see citing works

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.

Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.26.15183 · Cited by 238 · see citing works

Chemical Strategies for Activity‐Based Proteomics

Speers, A. E., & Cravatt, B. F. (2003) · ChemBioChem · doi:10.1002/cbic.200300721 · Cited by 259 · see citing works

Protein‐Reactive Natural Products

DRAHL, C., Cravatt, B. F., & Sorensen, E. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500900 · Cited by 251 · see citing works

Fumagillin Treatment of Intestinal Microsporidiosis

Molina, J., Tourneur, M., Sarfati, C., Chevret, S., de Gouvello, A., Gobert, J. G., Balkan, S., & Derouin, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012924 · Cited by 246 · see citing works

Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling

Evans, M. J., Saghatelian, A., Sorensen, E. J., & Cravatt, B. F. (2005) · Nature Biotechnology · doi:10.1038/nbt1149 · Cited by 230 · see citing works

Identification of eukaryotic peptide deformylases reveals universality of N‐terminal protein processing mechanisms

Giglione, C., Serero, A., Pierre, M., Boisson, B., & Meinnel, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5916 · Cited by 218 · see citing works

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

Hillebrand, L., Liang, X. J., Serafim, R. A. M., & Gehringer, M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01825 · Cited by 212 · see citing works

Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation

Zhang, T., Hatcher, J. M., Teng, M., Gray, N. S., & Kostic, M. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.09.012 · Cited by 178 · see citing works

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21 WAF1/CIP1

Zhang, Y., Griffith, E. C., Sage, J., Jacks, T., & Liu, J. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6427 · Cited by 177 · see citing works

N-terminal protein modifications: Bringing back into play the ribosome

Giglione, C., Fieulaine, S., & Meinnel, T. (2014) · Biochimie · doi:10.1016/j.biochi.2014.11.008 · Cited by 176 · see citing works

Chemical Strategies for Functional Proteomics

Adam, G. C., Sorensen, E. J., & Cravatt, B. F. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200006-mcp200 · Cited by 176 · see citing works

Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

Winter, P. M., Caruthers, S. D., Zhang, H., Williams, T. A., Wickline, S. A., & Lanza, G. M. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.06.003 · Cited by 166 · see citing works

Essential considerations for using protein–ligand structures in drug discovery

Warren, G. L., Do, T. D., Kelley, B. P., Nicholls, A. O., & Warren, S. D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.011 · Cited by 161 · see citing works

Control of protein life‐span by N‐terminal methionine excision

Giglione, C., Vallon, O., & Meinnel, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdg007 · Cited by 161 · see citing works

The chemistry and biology of fungal meroterpenoids (2009–2019)

Jiang, M., Wu, Z., Liu, L., & Chen, S. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob02162h · Cited by 156 · see citing works

Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites

Buey, R. M., Calvo, E., Barasoain, I., Pineda, O., Edler, M. C., Matesanz, R., Cerezo, G., Vanderwal, C. D., Day, B. W., Sorensen, E. J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio853 · Cited by 156 · see citing works

Profiling the specific reactivity of the proteome with non-directed activity-based probes

Adam, G. C., Cravatt, B. F., & Sorensen, E. J. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)90060-7 · Cited by 150 · see citing works

Cytotoxicity of occupationally and environmentally relevant mycotoxins

Bünger, J., Westphal, G., Mönnich, A., Hinnendahl, B., Hallier, E., & Müller, M. M. (2004) · Toxicology · doi:10.1016/j.tox.2004.05.007 · Cited by 146 · see citing works

Proteomics-based Target Identification

Towbin, H., Bair, K. W., DeCaprio, J. A., Eck, M. J., Kim, S., Kinder, F. R. J., Morollo, A. A., Mueller, D. R., Schindler, P. A., Song, H. K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309039200 · Cited by 146 · see citing works

Metallo-aminopeptidase inhibitors

Mucha, A., Drąg, M., Dalton, J. P., & Kafarski, P. K. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.026 · Cited by 139 · see citing works

Synthesis of the Furanosteroidal Antibiotic Viridin

Anderson, E. A., Alexanian, E. J., & Sorensen, E. J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353129 · Cited by 127 · see citing works

N‐Terminal Methionine Processing

Wingfield, P. T. (2017) · Current Protocols in Protein Science · doi:10.1002/cpps.29 · Cited by 125 · see citing works

Recent developments in self-resistance gene directed natural product discovery

Yan, Y., Liu, N., & Tang, Y. (2020) · Natural Product Reports · doi:10.1039/c9np00050j · Cited by 124 · see citing works

The antiangiogenic agent TNP-470 requires p53 and p21 CIP/WAF for endothelial cell growth arrest

Yeh, J.-R. J., Mohan, R., & Crews, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12782 · Cited by 120 · see citing works

Fumagillin: An Overview of Recent Scientific Advances and Their Significance for Apiculture

van den Heever, J. P., Thompson, T. S., Curtis, J. M., Ibrahim, A. A., & Pernal, S. F. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4055374 · Cited by 118 · see citing works

Chemical genetics: exploring and controlling cellular processes with chemical probes

Crews, C. M., & Splittgerber, U. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01425-5 · Cited by 116 · see citing works

Activity Based Probes for Proteases: Applications to Biomarker Discovery,Molecular Imaging and Drug Screening

Fonovič, M., & Bogyo, M. S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313623 · Cited by 112 · see citing works

Zinc coordination sphere in biochemical zinc sites

Auld, D. S. (2001) · Springer eBooks · doi:10.1007/978-94-017-3728-9_6 · Cited by 108 · see citing works

Therapeutic strategies for human microsporidia infections

Didier, E. S., Maddry, J. A., Brindley, P. J., Stovall, M. E., & Didier, P. J. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.3.419 · Cited by 107 · see citing works

Decoding the Function of Expansion Segments in Ribosomes

Fujii, K., Susanto, T. T., Saurabh, S., & Barna, M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.023 · Cited by 106 · see citing works

Fumagillin, a Mycotoxin of Aspergillus fumigatus: Biosynthesis, Biological Activities, Detection, and Applications

Guruceaga, X., Perez‐Cuesta, U., Abad, A., González, O., Alonso, R. M., Hernando, F. L., Ramirez‐Garcia, A., & Rementerı́a, A. (2019) · Toxins · doi:10.3390/toxins12010007 · Cited by 105 · see citing works

Role of Aminopeptidase in Angiogenesis

Sato, Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.772 · Cited by 104 · see citing works

Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action

Cardenas, M. E., Cruz, M. C., Poeta, M. D., Chung, N., Perfect, J. R., & Heitman, J. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.583 · Cited by 103 · see citing works

Structural Basis for the Functional Differences between Type I and Type II Human Methionine Aminopeptidases ,

Addlagatta, A., Hu, X. V., Liu, J. O., & Matthews, B. W. (2005) · Biochemistry · doi:10.1021/bi051691k · Cited by 102 · see citing works

Minute dosages of α ν β 3 ‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits

Winter, P. M., Schmieder, A. H., Caruthers, S. D., Keene, J. L., Zhang, H., Wickline, S. A., & Lanza, G. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-103929 · Cited by 102 · see citing works

ChemGPS-NPWeb: chemical space navigation online

Rosén, J., Lövgren, A., Kogej, T., Mureşan, S., Gottfries, J., & Backlund, A. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9255-y · Cited by 100 · see citing works

Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide

Zhou, H.-F., Yan, H., Hu, Y., Springer, L. E., Yang, X., Wickline, S. A., Pan, D., Lanza, G. M., & Pham, C. T. N. (2014) · ACS Nano · doi:10.1021/nn502372n · Cited by 101 · see citing works

A NF-?B p65 subunit is indispensable for activating manganese superoxide: Dismutase gene transcription mediated by tumor necrosis factor-?

Maehara, K., Hasegawa, T., & Isobe, K. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000601)77:3 · Cited by 52 · see citing works

Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells

Turk, B. E., Griffith, E. C., Wolf, S., BIEMANN, K., Chang, Y., & Liu, J. O. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80129-x · Cited by 100 · see citing works

Covalent Small Molecules as Enabling Platforms for Drug Discovery

Dalton, S. E., & Campos, S. (2019) · ChemBioChem · doi:10.1002/cbic.201900674 · Cited by 98 · see citing works

Discovering Disease-Associated Enzymes by Proteome Reactivity Profiling

Barglow, K. T., & Cravatt, B. F. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.023 · Cited by 99 · see citing works

Structural insights into the transcriptional and translational roles of Ebp1

Monie, T. P., Perrin, A. J., Birtley, J. R., Sweeney, T. R., Karakasiliοtis, I., Chaudhry, Y., Roberts, L. O., Matthews, S., Goodfellow, I., & Curry, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601817 · Cited by 97 · see citing works

Peptidase inhibitors in the MEROPS database

Rawlings, N. D. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.013 · Cited by 96 · see citing works

Beyond cysteine: recent developments in the area of targeted covalent inhibition

Mukherjee, H., & Grimster, N. P. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.011 · Cited by 95 · see citing works

Nanomedicine Strategies for Molecular Targets with Mri and Optical Imaging

Pan, D., Caruthers, S. D., Chen, J., Winter, P. M., Senpan, A., Schmieder, A. H., Wickline, S. A., & Lanza, G. M. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.5 · Cited by 92 · see citing works

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

Lanza, G., Winter, P. M., Caruthers, S. D., Hughes, M. S., Hu, G., Schmieder, A. H., & Wickline, S. A. (2010) · Angiogenesis · doi:10.1007/s10456-010-9166-0 · Cited by 91 · see citing works

Remodelling of the natural product fumagillol employing a reaction discovery approach

Balthaser, B. R., Maloney, M. C., Beeler, A. B., Porco, J. A. J., & Snyder, J. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1178 · Cited by 89 · see citing works

A Chemical and Genetic Approach to the Mode of Action of Fumagillin

Zhang, Y., Yeh, J.-R. J., Mara, A., Ju, R., Hines, J. F., Cirone, P., Griesbach, H. L., Schneider, I., Slusarski, D. C., Holley, S. A., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.07.010 · Cited by 89 · see citing works

Methionine aminopeptidase 2 and cancer

Selvakumar, P., Lakshmikuttyamma, A., Dimmock, J. R., & Sharma, R. K. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.11.001 · Cited by 88 · see citing works

Functional and Developmental Impact of Cytosolic Protein N-Terminal Methionine Excision in Arabidopsis

Ross, S., Giglione, C., Pierre, M., Espagne, C., & Meinnel, T. (2005) · PLANT PHYSIOLOGY · doi:10.1104/pp.104.056861 · Cited by 87 · see citing works

α v β 3 –Targeted nanotherapy suppresses inflammatory arthritis in mice

Zhou, H.-F., Chan, H., Wickline, S. A., Lanza, G. M., & Pham, C. T. N. (2009) · The FASEB Journal · doi:10.1096/fj.09-129874 · Cited by 86 · see citing works

Cereblon covalent modulation through structure-based design of histidine targeting chemical probes

Cruite, J. T., Dann, G. P., Che, J., Donovan, K. A., Ferrao, S., Ficarro, S. B., Fischer, E. S., Gray, N. S., Huerta, F., Kong, N. R., et al. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00078d · Cited by 82 · see citing works

The aminopeptidase from Aeromonas proteolytica: structure and mechanism of co-catalytic metal centers involved in peptide hydrolysis

Holz, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00470-2 · Cited by 80 · see citing works

Antimicrosporidial Activities of Fumagillin, TNP-470, Ovalicin, and Ovalicin Derivatives In Vitro and In Vivo

Didier, P. J., Phillips, J. N., Kuebler, D. J., Nasr, M., Brindley, P. J., Stovall, M. E., Bowers, L. C., & Didier, E. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00020-06 · Cited by 80 · see citing works

Angiogenesis Inhibitors Specific for Methionine Aminopeptidase 2 as Drugs for Malaria and Leishmaniasis

Zhang, P., Nicholson, D. E., Bujnicki, J. M., Su, X., Brendle, J. J., Ferdig, M. T., Kyle, D. E., Milhous, W. K., & Chiang, P. K. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256576 · Cited by 79 · see citing works

Drug treatment of microsporidiosis

Costa, S. F., & Weiss, L. M. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0174 · Cited by 78 · see citing works

Impact of the N-terminal amino acid on targeted protein degradation

Meinnel, T., Serero, A., & Giglione, C. (2006) · Biological Chemistry · doi:10.1515/bc.2006.107 · Cited by 75 · see citing works

Cancer Anti-angiogenic Therapy

Shimizu, K., & Oku, N. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.599 · Cited by 73 · see citing works

The Specificity in Vivo of Two Distinct Methionine Aminopeptidases in Saccharomyces cerevisiae

Chen, S., Vetro, J. A., & Chang, Y. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2675 · Cited by 72 · see citing works

Methionine aminopeptidases type I and type II are essential to control cell proliferation

Bernier, S. G., Taghizadeh, N. R., Thompson, C. D., Westlin, W., & Hannig, G. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20493 · Cited by 72 · see citing works

Development of covalent inhibitors: Principle, design, and application in cancer

Zheng, L., Li, Y., Wu, D., Xiao, H., Zheng, S., Wang, G., & Sun, Q. (2023) · MedComm – Oncology · doi:10.1002/mog2.56 · Cited by 71 · see citing works

Steady-State Kinetic Characterization of Substrates and Metal-Ion Specificities of the Full-Length and N-Terminally Truncated Recombinant Human Methionine Aminopeptidases (Type 2)

Yang, G. X., Kirkpatrick, R. B., Ho, T. F., Zhang, G., Liang, P., Johanson, K., Casper, D. J., Doyle, M. L., Marino, J. P., Thompson, S. K., et al. (2001) · Biochemistry · doi:10.1021/bi010806r · Cited by 71 · see citing works

Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection

Molina, J.-M., Goguel, J., Sarfati, C., Michiels, J.-F., Desportes-Livage, I., Balkan, S., Chastang, C., Cotte, L., Maslo, C., Struxiano, A., et al. (2000) · AIDS · doi:10.1097/00002030-200007070-00006 · Cited by 71 · see citing works

The Development of MetAP-2 Inhibitors in Cancer Treatment

Yin, S.-Q., Wang, J.-J., Zhang, C.-M., & Liu, Z.-P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320709 · Cited by 68 · see citing works

Nanomedicine Opportunities for Cardiovascular Disease with Perfluorocarbon Nanoparticles

Lanza, G. M., Winter, P. M., Caruthers, S. D., Hughes, M. S., Cyrus, T., Marsh, J. N., Neubauer, A. M., Partlow, K. C., & Wickline, S. A. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.321 · Cited by 67 · see citing works

Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products

Vitale, G. A., Geibel, C., Minda, V., Wang, M., Aron, A. T., & Petras, D. (2024) · Natural Product Reports · doi:10.1039/d3np00050h · Cited by 66 · see citing works

Recent progress in covalent warheads for in vivo targeting of endogenous proteins

Shindo, N., & Ojida, A. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116386 · Cited by 66 · see citing works

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Wang, J., Sheppard, G. S., Lou, P., Kawai, M., BaMaung, N. Y., Erickson, S., Tucker, L. A., Park, C. Y., Bouska, J. J., Wang, Y.-C., et al. (2003) · PubMed · Cited by 65 · see citing works

Therapeutic targets for the treatment of microsporidiosis in humans

Han, B., & Weiss, L. M. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538360 · Cited by 64 · see citing works

Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease

Veale, C. G. L. (2019) · ChemMedChem · doi:10.1002/cmdc.201800755 · Cited by 60 · see citing works

Fungal BGCs for Production of Secondary Metabolites: Main Types, Central Roles in Strain Improvement, and Regulation According to the Piano Principle

Zhgun, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311184 · Cited by 65 · see citing works

Small-molecule inhibitors of the cell cycle

Crews, C. M., & Mohan, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00050-2 · Cited by 63 · see citing works

MetAP-like Ebp1 occupies the human ribosomal tunnel exit and recruits flexible rRNA expansion segments

Wild, K., Aleksić, M., Lapouge, K., Juaire, K. D., Flemming, D., Pfeffer, S., & Sinning, I. (2020) · Nature Communications · doi:10.1038/s41467-020-14603-7 · Cited by 63 · see citing works

The 1.15Å Crystal Structure of the Staphylococcus aureus Methionyl-aminopeptidase and Complexes with Triazole Based Inhibitors

Oefner, C., Douangamath, A., D'Arcy, A., Häfeli, S., Mareque, D., Sweeney, A. M., Padilla, J., Pierau, S., Schulz, H., Thormann, M., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00862-3 · Cited by 63 · see citing works

(−)‐FR182877 Is a Potent and Selective Inhibitor of Carboxylesterase‐1

Adam, G. C., Vanderwal, C. D., Sorensen, E. J., & Cravatt, B. F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352576 · Cited by 63 · see citing works

Cotranslational sorting and processing of newly synthesized proteins in eukaryotes

Gamerdinger, M., & Deuerling, E. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.10.003 · Cited by 62 · see citing works

Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model

Chun, E., Han, C. K., Yoon, J. H., Sim, T. B., Kim, Y., & Lee, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20687 · Cited by 62 · see citing works

Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles

Zhou, H.-F., Yan, H., Senpan, A., Wickline, S. A., Pan, D., Lanza, G. M., & Pham, C. T. N. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.005 · Cited by 61 · see citing works

Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer

Shin, S. J., Beech, J., & Kelly, K. A. (2012) · Integrative Biology · doi:10.1039/c2ib20047c · Cited by 61 · see citing works

Metal Ions as Cofactors for the Binding of Inhibitors to Methionine Aminopeptidase: A Critical View of the Relevance of In Vitro Metalloenzyme Assays

Schiffmann, R., Heine, A., Klebe, G., & Klein, C. D. P. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500592 · Cited by 60 · see citing works

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.

Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.26.15183 · Cited by 238 · see citing works

Understanding the Selectivity of Fumagillin for the Methionine Aminopeptidase Type II

Klein, C. D. P., & Folkers, G. (2003) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000003108748036 · Cited by 18 · see citing works

Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2

Han, C. K., Ahn, S. K., Choi, N. S., Hong, R. K., Moon, S. K., Chun, H. S., Lee, S. J., Kim, J. W., Hong, C. I., Kim, D., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00577-6 · Cited by 58 · see citing works

Carbamate Analogues of Fumagillin as Potent, Targeted Inhibitors of Methionine Aminopeptidase-2

Arico-Muendel, C. C., Benjamin, D. R., Caiazzo, T., Centrella, P. A., Contonio, B. D., Cook, C. M., Doyle, E., Hannig, G., Labenski, M., Searle, L. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901260k · Cited by 29 · see citing works

Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity

Morgen, M., Jöst, C., Malz, M., Janowski, R., Niessing, D., Klein, C. D. P., Gunkel, N., & Miller, A. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00755 · Cited by 38 · see citing works